sb010
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2011 (NCT01470911)
Timeline
Indications
Studied for
Mechanism of action
inhibitor - gata3
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sb010
- sb010
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01743768 | Phase 2 | Dec 1, 2012 | Fraunhofer, Sterna Biologicals GmbH & Co. KG |
| NCT01554319 | Phase 1 | Apr 1, 2012 | CRS Clinical Research Services Kiel GmbH, Sterna Biologicals GmbH & Co. KG |
| NCT01577953 | Phase 1 | Apr 1, 2012 | Fraunhofer, Sterna Biologicals GmbH & Co. KG |
| NCT01470911 | Phase 1 | Nov 1, 2011 | CRS Clinical Research Services Kiel GmbH, Sterna Biologicals GmbH & Co. KG |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sterna Biologicals GmbH & Co. KG | For profit | 4 | 4 | 2 | 2011 |
| CRS Clinical Research Services Kiel GmbH | For profit | 2 | 0 | 1 | 2011 |
| Fraunhofer | For profit | 2 | 0 | 2 | 2012 |
3 organizations
Page 1 / 1